Eloxx Pharmaceuticals (ELOX) Return on Assets [ROA] (2011 - 2026)
Eloxx Pharmaceuticals (ELOX) recorded Return on Assets [ROA] of -30.62% in Q2 2026, up 123.66 percentage points from the prior quarter.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Eloxx Pharmaceuticals reported Return on Assets [ROA] of -156.15%, down 50.86 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of -75.19 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -105.29% in FY2024 (+46.13 pp), -151.42% in FY2023 (-48.36 pp), -103.06% in FY2022 (+81.28 pp) and -184.34% in FY2021 (-103.39 pp).
- The Q2 2026 figure is the highest quarterly Return on Assets [ROA] in data going back to Q4 2015.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 25.23 percentage points in Q2 2022, against a drop of 294.54 percentage points in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.14% |
| 10 | Eloxx Pharmaceuticals | 87.44 Mn | 13.76 Mn | - | -30.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.62% |
| Mar 31, 2026 | -154.27% |
| Dec 31, 2023 | -439.59% |
| Sep 30, 2023 | -314.12% |
| Jun 30, 2023 | -338.35% |
| Mar 31, 2023 | -201.31% |
| Dec 31, 2022 | -145.05% |
| Sep 30, 2022 | -135.69% |
| Jun 30, 2022 | -114.32% |
| Mar 31, 2022 | -155.97% |
| Dec 31, 2021 | -131.89% |
| Sep 30, 2021 | -104.21% |
| Jun 30, 2021 | -139.55% |
| Mar 31, 2021 | -120.78% |
| Dec 31, 2020 | -111.47% |
| Sep 30, 2020 | -105.66% |
| Jun 30, 2020 | -102.87% |
| Mar 31, 2020 | -96.83% |
| Dec 31, 2019 | -77.92% |
| Sep 30, 2019 | -70.95% |
API Access
Eloxx Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();